ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment.
Spinelli, Antonino ; Bonovas, Stefanos ; Burisch, Johan ; Kucharzik, Torsten ; Adamina, Michel ; Annese, Vito ; Bachmann, Oliver ; Bettenworth, Dominik ; Chaparro, Maria ; Czuber-Dochan, Wladyslawa ... show 10 more
Spinelli, Antonino
Bonovas, Stefanos
Burisch, Johan
Kucharzik, Torsten
Adamina, Michel
Annese, Vito
Bachmann, Oliver
Bettenworth, Dominik
Chaparro, Maria
Czuber-Dochan, Wladyslawa
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2022-02-23
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
This is the second of a series of two articles reporting the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of adult patients with ulcerative colitis [UC]. The first article is focused on medical management, and the present article addresses medical treatment of acute severe ulcerative colitis [ASUC] and surgical management of medically refractory UC patients, including preoperative optimisation, surgical strategies, and technical issues. The article provides advice for a variety of common clinical and surgical conditions. Together, the articles represent an update of the evidence-based recommendations of the ECCO for UC.
Citation
Spinelli A, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V, Bachmann O, Bettenworth D, Chaparro M, Czuber-Dochan W, Eder P, Ellul P, Fidalgo C, Fiorino G, Gionchetti P, Gisbert JP, Gordon H, Hedin C, Holubar S, Iacucci M, Karmiris K, Katsanos K, Kopylov U, Lakatos PL, Lytras T, Lyutakov I, Noor N, Pellino G, Piovani D, Savarino E, Selvaggi F, Verstockt B, Doherty G, Raine T, Panis Y. ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment. J Crohns Colitis. 2022 Feb 23;16(2):179-189. doi: 10.1093/ecco-jcc/jjab177
Type
Article